AstraZeneca

Thumbnail for AKUHN to study nurse navigation in breast cancer care in Kenya

6 March 2025

AKUHN to study nurse navigation in breast cancer care in Kenya

Thumbnail for AstraZeneca buys FibroGen’s China subsidiary for US$160M, securing Roxadustat

21 February 2025

AstraZeneca buys FibroGen’s China subsidiary for US$160M, securing Roxadustat

Thumbnail for AstraZeneca’s Healthy Heart Africa expands focus to CKD after a decade of success

16 February 2025

AstraZeneca’s Healthy Heart Africa expands focus to CKD after a decade of success

Thumbnail for AstraZeneca’s Imfinzi recommended for EU approval in lung cancer

6 February 2025

AstraZeneca’s Imfinzi recommended for EU approval in lung cancer

Thumbnail for AstraZeneca receives positive NICE recommendations for lung cancer treatments

27 January 2025

AstraZeneca receives positive NICE recommendations for lung cancer treatments

Thumbnail for AstraZeneca invests US$570M in Canada, creating 700 jobs

24 January 2025

AstraZeneca invests US$570M in Canada, creating 700 jobs

Thumbnail for Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

23 January 2025

Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

Thumbnail for AstraZeneca elevates South Africa’s role in global health research

11 November 2024

AstraZeneca elevates South Africa’s role in global health research

Thumbnail for AstraZeneca’s Tagrisso gains FDA nod for stage III lung cancer

30 September 2024

AstraZeneca’s Tagrisso gains FDA nod for stage III lung cancer

Thumbnail for FluMist gets FDA approval for self-administration

24 September 2024

FluMist gets FDA approval for self-administration